Federal health officials have released a 173-page guide urging state Medicaid programs to strengthen oversight of applied behavior analysis, the most common therapy for children with autism, after program spending rose 421 percent in four years.
The Centers for Medicare and Medicaid Services published the document on August 4, 2026. According to the agency's announcement, spending on ABA in Medicaid and the Children's Health Insurance Program increased 421 percent between 2021 and 2025, far outpacing a 67 percent rise in the number of children with an autism spectrum disorder diagnosis receiving services.
For families with a child in ABA, the immediate question is whether services are about to change. CMS says they are not being restricted by this action. The agency states the toolkit does not establish new federal requirements, does not reduce Early and Periodic Screening, Diagnostic and Treatment obligations, does not endorse any single treatment approach, and does not direct states to limit access to medically necessary care.
Billing Integrity Separated from Clinical Value
The distinction at the center of this story is one parents should hold onto: the federal action addresses documentation, billing and program oversight, not whether ABA works.
The toolkit itself is explicit on this point, stating that "CMS does not endorse or require any particular treatment modality" for autism spectrum disorder. It carries no new federal mandates, and states decide individually whether and how to apply it.
ABA is an intensive behavioral intervention delivered one-on-one or in small groups, often for many hours per week, aimed at building communication, social and daily living skills. Its intensity is what makes it expensive, and the hourly billing structure is what makes documentation central to oversight.
The guidance was informed by Medicaid data, peer-reviewed literature and stakeholder input, drawing on a review of more than 40 literature sources and more than 240 state-level coverage and policy references, along with input from state agencies, providers and advocates.
The Numbers Behind the Federal Concern
The spending figures are the substance of the case CMS is making. Medicaid and CHIP spending on ABA rose from roughly $1.94 billion to about $10.1 billion between 2021 and 2025.
The mismatch matters more than the total. Over the same period, the number of Medicaid and CHIP beneficiaries with an autism diagnosis receiving any service grew 67 percent, from 1.15 million to 1.92 million, and only a small share of them received ABA. CMS argues that gap raises questions about whether services are consistently driven by medical need.
The agency also points to enforcement history, citing investigations, prosecutions and convictions involving kickbacks and harm to children. CMS Administrator Mehmet Oz said in the announcement that "Every dollar lost to fraud or waste" is a dollar that cannot reach a child who needs it.
Provider organizations have pushed back on the framing, arguing that ABA benefits many children with autism and should retain Medicaid coverage. The toolkit itself cites practice guidelines developed by the Council of Autism Service Providers, a provider trade association.
State Programs Where Change Is Already Underway
The toolkit does not arrive in a vacuum. Several states moved first, and families in those states are already seeing effects.
North Carolina offers the clearest example. State and federal Medicaid spending there surpassed $505 million in one year, up from $1.9 million five years earlier, with costs projected by the state health department to exceed $1 billion by 2027. State lawmakers responded by enacting new restrictions, and North Carolina families now face new therapy rules that limit telehealth delivery, require in-person initial assessments and tighten provider enrollment standards. The state attorney general has also opened an investigation into ABA billing.
Because Medicaid is administered state by state, the practical effect of the federal toolkit will depend entirely on what individual state agencies choose to adopt. Two families in neighboring states with identical diagnoses may see very different rules.
Practical Steps for Parents and Caregivers
Nothing in the federal action requires a parent to do anything today. Children currently receiving authorized services should continue them, and no family should discontinue therapy in anticipation of a policy change.
Families can reduce the risk of disruption by keeping their own records. That means retaining the diagnostic evaluation, current treatment plan, and authorized service hours, along with any progress reports the provider issues. If a state tightens documentation standards, a family that already holds this paperwork is in a stronger position during reauthorization.
Parents can also ask their provider direct questions without implying wrongdoing: who supervises the technician delivering therapy and how often, how prescribed hours were determined, how progress is measured, and how the provider documents sessions. Those are the areas oversight reviews typically examine.
If services are reduced or denied, families retain appeal rights under Medicaid, and EPSDT obligations for children under 21 remain in force. State Medicaid offices, managed care plan member services and local disability rights organizations can explain the appeal process. Parents should not accept an informal reduction without a written notice explaining it.
The next developments to watch are state-level responses, since each Medicaid agency decides whether and how to apply the toolkit, and further federal audit findings. MedicalDaily will report state adoption decisions and any changes to coverage rules as they are issued.
The bottom line: the newest confirmed development is federal guidance urging tighter oversight of Medicaid-funded ABA billing, the families most affected are those relying on Medicaid for autism therapy in states that adopt stricter documentation rules, and the guidance does not by itself change any child's authorized services.
Frequently Asked Questions
What did CMS actually release? A 173-page state Medicaid and CHIP toolkit on applied behavior analysis, offering states guidance on coverage design, documentation standards, payment approaches and program oversight.
Does this cut autism services? No. CMS states the toolkit does not establish new federal requirements, does not reduce EPSDT obligations, and does not direct states to limit medically necessary care.
Why did federal officials act now? Medicaid and CHIP spending on ABA rose 421 percent between 2021 and 2025, from roughly $1.94 billion to about $10.1 billion, outpacing growth in the number of children with an autism diagnosis receiving services.
Is CMS saying ABA does not work? No. The agency states it does not endorse or require any particular treatment approach. The action concerns billing integrity and oversight, not clinical effectiveness.
Could a child lose therapy hours? Any change depends on what a state Medicaid agency decides to adopt. Some states, including North Carolina, have already tightened rules independently of this toolkit.
What should parents keep on file? The diagnostic evaluation, current treatment plan, authorized hours and provider progress reports, all of which support reauthorization requests.
What if services are denied or reduced? Families have Medicaid appeal rights and should request a written notice. State Medicaid offices and disability rights organizations can explain the process.
